CardioExchange Archive

January 5th, 2015

Selections from Richard Lehman’s Literature Review: January 5th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include metformin in patients with type 2 diabetes and kidney disease, mortality and treatment patterns among patients hospitalized with acute CV conditions during national cardiology meetings, and more.

---

November 3rd, 2014

Selections from Richard Lehman’s Literature Review: November 3rd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dual-antiplatelet treatment beyond one year after DES implantation, reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome, and more.

---

October 13th, 2014

Selections from Richard Lehman’s Literature Review: October 13th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include a comparison of once-weekly dulaglutide and once-daily liraglutide in metformin-treated patients with type 2 diabetes and variation in patients’ perceptions of elective PCI in stable CAD.

---

June 16th, 2014

Selections from Richard Lehman’s Literature Review: June 16th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include statins and physical activity in older men, transitional care interventions to prevent heart-failure readmissions, and more.

---

October 22nd, 2013

Are Sulfonylureas Dangerous?

Kasia Lipska, MD, MHS

Endocrinologist Kasia Lipska shares her thoughts about a presentation by Craig Currie at this year’s annual meeting of the European Association for the Study of Diabetes.

---

September 26th, 2013

Increase In Deaths Linked To First-Line Treatment With Sulfonylureas

Larry Husten, PHD

First-line treatment with sulfonylureas instead of metformin in people with type 2 diabetes is associated with a significantly elevated risk of death, according to results from an observational study presented at the European Association for the Study of Diabetes (EASD) meeting in Barcelona. Although guidelines do not recommend the use of sulfonylureas for first-line treatment, the drugs are still […]

---

November 12th, 2012

Selections from Richard Lehman’s Literature Review: November 12th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include multivitamins for the prevention of CVD in men, the TRILOGY ACS trial, statin use and reduced cancer mortality, and more.

---

April 6th, 2011

Large Study Finds Wide Differences in Risks Among Diabetes Drugs

Larry Husten, PHD

A very large observational study has found an increase in death and cardiovascular risk in people taking insulin secretagogues (ISs) compared with those taking metformin. Tina Ken Schramm and colleagues, reporting in the European Heart Journal, analyzed data from the entire population of Denmark and identified 107,806  people who initiated therapy with an IS or […]

---